APOA1 and atherosclerosis: Because peptides that bind cholesterol lipids have potential as anti-inflammatory and/or anti-atherosclerosis agents we also examined the binding of other lipids by the “Oxpholipin” peptides, as well as their activity in a monocyte chemotaxis assay that guided the initial development of L-4F and related apoA-I-mimetic peptides.